Triple-peptide receptor targeting in vitro allows detection of all tested gut and bronchial NETs

Journal of Nuclear Medicine

Volumn 56, Issue 4, 2015, Pages 613-615

  Reubi, Jean Claude ^a   Waser, Beatrice ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

GLP 1 receptors; Incretin receptors; Multireceptor imaging; Neuroendocrine tumors; Somatostatin receptors

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE I 125; GLUCOSE DEPENDENT INSULINOTROPIC PEPTIDE RECEPTOR; GLUCOSE DEPENDENT INSULINOTROPIC PEPTIDE[1-30] I 125; OCTREOTIDE[3 TYROSINE] I 125; RADIOLIGAND; SOMATOSTATIN RECEPTOR 2; UNCLASSIFIED DRUG; GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GLUCAGON RECEPTOR; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; HORMONE RECEPTOR; LIGAND; OCTREOTIDE; PROTEIN BINDING; RADIOACTIVE IODINE; RECEPTOR; SOMATOSTATIN RECEPTOR; TYROSINE;

ARTICLE; AUTORADIOGRAPHY; BRONCHUS TUMOR; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; ILEUM TUMOR; IN VITRO STUDY; INSULINOMA; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN TARGETING; CHEMISTRY; DIAGNOSTIC USE; METABOLISM; METASTASIS;

AUTORADIOGRAPHY; BRONCHIAL NEOPLASMS; HUMANS; INSULINOMA; IODINE RADIOISOTOPES; LIGANDS; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; OCTREOTIDE; PANCREATIC NEOPLASMS; PROTEIN BINDING; RECEPTORS, GASTROINTESTINAL HORMONE; RECEPTORS, GLUCAGON; RECEPTORS, PEPTIDE; RECEPTORS, SOMATOSTATIN; TYROSINE;

EID: 84928243102     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.153189     Document Type: Article

References (16)

1. Reubi JC. Peptide receptors as molecular targets for cancer diagnosis and therapy. Endocr Rev. 2003;24:389-427.
2. Reubi JC, Waser B. Concomitant expression of several peptide receptors in neuroendocrine tumors as molecular basis for in vivo multireceptor tumor targeting. Eur J Nucl Med Mol Imaging. 2003;30:781-793.
3. Bodei L, Kidd M, Prasad V, Baum RP, Drozdov I, Modlin IM. The future of nuclear medicine imaging of neuroendocrine tumors: on a clear day one might see forever. Eur J Nucl Med Mol Imaging. 2014;41:2189-2193.
4. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med. 1993;20:716-731.
5. Reubi JC, Schaer JC, Waser B. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res. 1997;57:1377-1386.
6. Waser B, Rehmann R, Sanchez C, Fourmy D, Reubi JC. Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors. J Clin Endocrinol Metab. 2012;97:482-488.
7. Körner M, Stockli M, Waser B, Reubi JC. GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med. 2007;48:736-743.
8. Christ E, Wild D, Ederer S, et al. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study. Lancet Diabetes Endocrinol. 2013;1:115-122.
9. Wild D, Caplin M, Christ E, et al. Glucagon-like peptide-1 vs. somatostatin receptor targeting in malignant insulinomas. J Nucl Med. 2011;52:1073-1078.
10. Wild D, Mäcke H, Christ E, Gloor B, Reubi JC. Glucagon-like peptide 1-receptor scans to localize occult insulinomas. N Engl J Med. 2008;359:766-768.
11. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC. Somatostatin receptor scintigraphy. In: Freeman LM, ed. Nuclear Medicine Annual 1995. New York, NY: Raven Press; 1995:1-50.
12. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013;339:1546-1558.
13. Reubi C, Gugger M, Waser B. Coexpressed peptide receptors in breast cancers as molecular basis for in vivo multireceptor tumor targeting. Eur J Nucl Med Mol Imaging. 2002;29:855-862.
14. 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors. J Nucl Med. 2013;54:364-372.
15. Wild D, Fani M, Fischer R, et al. Comparison of somatostatin receptor agonist and antagonist for peptide receptor radionuclide therapy: a pilot study. J Nucl Med. 2014;55:1248-1252.
16. Gourni E, Waser B, Clerc P, Fourmy D, Reubi JC, Maecke HR. The glucose-dependent insulinotropic polypeptide receptor: a novel target for neuroendocrine tumor imaging - first preclinical studies. J Nucl Med. 2014;55:976-982.